Pluristem Therapeutics Inc (PSTI)

[El Mago]

WALTHAM, Mass., Sept. 13 /PRNewswire/ -- Millennium Research Group
(MRG) has conducted a detailed analysis of the stem cell therapy market in
its US Markets for Stem Cell Therapies 2007 report. The analysis reveals
that although the market for stem cell therapies is in its infancy, it will
grow rapidly as products are approved in the US. Today, only two products
are on the market, but by 2017, almost 90 are expected to be available.
Stem cells have regenerative capabilities, and promise lasting
treatments for chronic disorders and potential cures for currently
'incurable' diseases. In 2007, the US stem cell therapies market earned
over $25 million in revenues, with only two orthopedic products available
in the US-Osiris Therapeutics' Osteocel, and Blackstone Medical's Trinity.
Aside from these two products, the development of the US market for stem
cell therapies is largely dependent on the success of clinical trials,
regulatory approval, and public acceptance. The first products in the
cardiovascular, diabetes, neurological, and tissue and organ stem cell
therapy markets are expected to enter the market between 2009 and 2013. The
entry of these products will open up a new realm of treatable disorders,
offering hope to patients and vast market potential.
"This market has almost everything going its way", says Chris Schutz,
senior analyst at MRG. "The big question mark however is the political and
public support. The prevalence of potentially treatable disorders, unmet
medical needs, rising health care costs, growth in the aging population,
and the success of the first stem cell therapy products are all factors
that will drive this market upward through 2017."
The US Markets for Stem Cell Therapies 2007 report includes coverage of
companies offering or developing products for the stem cell therapy market,
including Aastrom Biosciences, Advanced Cell Technologies, Arteriocyte,
Blackstone Medical, Cytori Therapeutics, Geron, Harvest Technologies,
International Stem Cell Corporation, and Osiris Therapeutics.
About Stem Cells
Stem cells are primal cells that are derived from highly proliferative
tissues. These cells are precursors to every organ, tissue, and cell in the
human body. Because of their universality and ability to repair or replace
damaged tissue, stem cells have the potential to cure injuries and diseases
such as orthopedic degenerative disease, cardiovascular disease, diabetes,
neurological disease, cancer, retinal disease, and other chronic and
autoimmune disorders.
About Millennium Research Group
Millennium Research Group (http://www.MRG.net), a Decision Resources, Inc.
company (http://www.DecisionResources.com), is the global authority on medical
technology market intelligence and a leading provider of strategic
information to the health care sector. Focused solely on the medical
device, pharmaceutical, and biotechnology industries, the company provides
its clients with the benefits of its specialized industry expertise through
published reports and customized consulting services.
For more information, contact:
Amy Krohn
Millennium Research Group
416-364-7776 x101